Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail
-

Emsam (Selegiline) Transdermal System
Company: Somerset Pharmaceuticals, Inc.
Application No.:  021336 & 021708
Approval Date: 02/27/2006

 

Date created:  September 10, 2007

Back to Top    Drugs@FDA

 

Note: Documents in PDF format require the Adobe Acrobat Reader®.

-
-